doi:10.2478/rjim-2023-0001
FDA safety-risk list
In addition to weight loss, Orforglipron is being studied for blood sugar control in type 2 diabetes 2
Together, we can discuss the potential benefits, possible side effects, and determine if tirzepatide is the best fit within your overall personalized plan, including diet, exercise, and lifestyle adjustments
Novo Nordisk has highlighted strong early uptake for its obesity pill in the US in early 2026 , framing oral semaglutide in obesity as part of its growth strategy beyond injectables
As of mid-2026, typical cash pricing looks roughly like this: Wegovy (semaglutide injection): around $349 per month for standard maintenance doses, with introductory pricing near $199 per month for the first fills of the lowest doses